ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
Want to see AVBP full AI Analyst Report?
ArriVent BioPharma, Inc. (AVBP) Ownership Overview
9.57% Insiders
11.89% Mutual Funds
56.55% Other Institutional Investors
10.10% ETFs
11.88% Public Companies and
Individual Investors
The ownership structure of ArriVent BioPharma, Inc. (AVBP) stock is a mix of institutional, retail, and individual investors. Approximately 78.55% of the company’s stock is owned by Institutional Investors, 9.57% is owned by Insiders, and 11.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 03, 2026 | xxxxxxxxxxxxx | $12983320 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $3406032 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,929,117 | Insider | 8.44% | 132,568,408 | |
| 1,787,003 | Institution | 3.84% | 60,293,481 | |
| 1,771,821 | Institution | 3.80% | 59,781,241 | |
| 1,511,142 | Institution | 3.24% | 50,985,931 | |
| 1,493,078 | Institution | 3.21% | 50,376,452 | |
| 883,440 | Institution | 1.90% | 29,807,266 | |
| 530,213 | Insider | 1.14% | 17,889,387 | |
| 495,653 | Institution | 1.06% | 16,723,332 | |
| 447,770 | Institution | 0.96% | 15,107,760 | |
| 325,718 | Institution | 0.70% | 10,989,725 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,787,003 | Institution | 3.84% | 60,293,481 | |
| 1,493,078 | Institution | 3.21% | 50,376,452 | |
| 495,653 | Institution | 1.06% | 16,723,332 | |
| 447,770 | Institution | 0.96% | 15,107,760 | |
| 325,718 | Institution | 0.70% | 10,989,725 | |
| 314,775 | Institution | 0.68% | 10,620,509 | |
| 175,463 | Institution | 0.38% | 5,920,122 | |
| 121,840 | Institution | 0.26% | 4,110,882 | |
| 89,889 | Institution | 0.19% | 3,032,855 | |
| 61,008 | Institution | 0.13% | 2,058,410 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,155,263 | Institution | 2.48% | 34,969,811 | |
| 834,002 | Institution | 1.79% | 27,271,865 | |
| 767,167 | Institution | 1.65% | 25,884,215 | |
| 344,534 | Institution | 0.74% | 10,429,044 | |
| 268,501 | Institution | 0.58% | 9,059,224 | |
| 225,908 | Institution | 0.49% | 7,622,136 | |
| 165,782 | Institution | 0.36% | 5,018,221 | |
| 163,986 | Institution | 0.35% | 5,532,888 | |
| 83,255 | Institution | 0.18% | 2,809,024 | |
| 72,990 | Institution | 0.16% | 2,209,407 |
FAQ
Who Owns ArriVent BioPharma, Inc. (AVBP)?
According to the latest TipRanks data, approximately 56.55% of the company's stock is held by institutional investors, 9.57% is held by insiders, and 11.88% is held by retail investors.
What percentage of ArriVent BioPharma, Inc. (AVBP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 56.55% of ArriVent BioPharma, Inc. (AVBP) stock is held by institutional investors.
What percentage of ArriVent BioPharma, Inc. (AVBP) stock is held by retail investors?
According to the latest TipRanks data, approximately 11.88% of ArriVent BioPharma, Inc. (AVBP) stock is held by retail investors.
Who owns the most shares of ArriVent BioPharma, Inc. (AVBP)?
Hillhouse Capital Management, Ltd. owns the most shares of ArriVent BioPharma, Inc. (AVBP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.